360 High-Risk Vulnerability Immunization Tool V2.0 vs Atera Network Discovery: 2026 Comparison

360 High-Risk Vulnerability Immunization Tool V2.0

Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.

Atera Network Discovery

SMB and mid-market IT teams already running Atera's RMM will find genuine value in Network Discovery because it eliminates the separate tool tax for basic asset inventory and CVE scanning. The NMAP-powered scanning integrates directly into your existing RMM workflows, cutting the overhead of maintaining a standalone vulnerability scanner. Where it falls short is in forensic depth; this is asset discovery and port-based CVE detection, not a replacement for active vulnerability assessment tools like Nessus or Qualys that fingerprint software versions and test exploitability. Worth deploying if you need continuous visibility into what's connecting to your network. Not worth it if you're already committed to a dedicated CVSS-scoring vulnerability platform.